1. Guan W, Ni Z, Hu Y, Liang W, Ou C, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl Med. 2020; 382:1708-1720. Available from https://www.nejm.org/doi/10.1056/NEJMoa2002032
2. Liu K, Fang Y, Deng Y, Liu W, Wang MF, et al. Clinical Characteristics of Novel Coronavirus Cases in Tertiary Hospitals in Hubei Province. CMJ. 2020; 1:1-7. doi: 10.1097/CM9.0000000000000744
3. Gennaro F D, Pizzol D, Marotta C, Antunes M, Racalbuto V, et al. Coronavirus Disease (COVID-19) Current Status and Future Perspectives: A Narrative Review. Int J Environ Res Public Health. MDPI. 2020; 17(8):2690-2703. Available from https://doi.org/10.3390/ijerph17082690
4. Gao Y, Li T, Han M, Li X, Wu D, et al. Diagnostic Utility of Laboratory Data Determinations for Patients with the Severe COVID-19. J Med Virol. 2020; 1:1-6. Available from https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.25770
5. Docea A O, Tsatsakis A, Albulescu D, Cristea O, Zlatian O, et al. A New Threat from an Old Enemy: Re-Emergence of Coronavirus (Review). Int J Mol Med. 2020; 45:1631-1643. doi: 10.3892/ijmm.2020.4555
6. Zhang T, Wu Q, Zhang Z. Probable Pangolin Origin of SARS-CoV-2 Associated with COVID-19 Outbreak. Cur Biol. Elsevier Inc. 2020; 30:1346-1351. Available from https://doi.org/10.1016/j.cub.2020.03.022
7. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, et al. The Origin, Transmission and Clinical Therapies on Coronavirus Disease 2019 (COVID-19) Outbreak – an Update on the Status. Military Medical Research. 2020; 7:11-21. Available from https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-020-00240-0
8. World Health Organization. WHO guidelines on drawing blood: best practices in phlebotomy. WHO Library Cataloguing-in-Publication Data. 2010; 1(2):9-18. Available from http://www.euro.who.int/__data/assets/pdf_file/0005/268790/WHO-guidelines-on-drawing-blood-best-practices-in-phlebotomy-Eng.pdf?ua-1
9. World Health Organization. Laboratory Quality Management System: Handbook. WHO Library Cataloguing-in-Publication Data. 2011; 1(6-8):71-98. Available from https://www.who.int/ihr/publications/lqms_en.pdf
10. Liang T. Handbook of COVID-19 Prevention and Treatment. Zhejiang University School of Medicine. 2020; 1(2):18-22. Available from https://www.researchgate.net/profile/Ligen_Yu/publication/339998871_Handbook_of_COVID-19_Prevention_and_Treatment/links/5e71cde84585152cdbfa8c11/Handbook-of-COVID-19-Prevention-and-Treatment.pdf
11. Huang C, Wang Y, Li X, Ren L, Zhao J, et al. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet. Elsevier. 2020; 1(1):1-10. Available from https://www.thelancet.com/action/showPdf?pii=S0140-6736%2820%2930183-5
12. Fan BE, Chong VCL, Chan SSW, Lim GH, Lim KGE, et al. Hematologic Parameters in Patients with COVID-19 Infection. Am J Hematol. 2020;1-4. doi: 10.1002/ajh.25774
13. Barnes BJ, Adrover JM, Baxter-Stoltzfus A, Borczuk A, Cools-Lartigue J, et al. Targeting Potential Drivers of COVID-19: Neutrophil Extracellular Traps. J Exp Med. 2020; 217(6):1-7. Available from https://doi.org/10.1084/jem.20200652
14. Cao W, Shi L, Chen L, Xu X, Wu Z. Clinical Features and Laboratory Inspection of Novel Coronavirus Pneumonia (COVID-19) in Xiangyang, Hubei. British Medical Journal. 2020; 1(1):1-11. Available from https://doi.org/10.1101/2020.02.23.20026963
15. Wang F, Nie J, Wang H, Xiong Y, Deng L, et al. Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia. The Journal of Infectious Diseases. 2020; XX:1-8. Available from https://doi.org/10.1093/infdis/jiaa150
16. Liu J, Li S, Liu J, Liang B, Wang X, et al. Longitudinal Characteristics of Lymphocyte Response and Cytokine Profiles in the Peripheral Blood of SARS-CoV-2 Infected Patients. British Medical Journal. 2020; 1(1):1-35. Available from https://www.medrxiv.org/content/10.1101/2020.02.16.20023671v2.full.pdf
17. Tan L, Wang Q, Zhang D, Ding J, Huang Q, et al. Lymphopenia Predicts Disease Severity of COVID-19: a Descriptive and Predictive Study. Nature Research Journal. 2020; 5(33):1-3. Available from https://www.nature.com/articles/s41392-020-0148-4.pdf
18. Yang AP, Liu JP, Tao WQ, Li HM. The Diagnostic and Predictive Role of NLR, d-NLR and PLR in COVID-19 Patients. International Immunopharmacology. 2020; 84:1-7. Available from https://reader.elsevier.com/reader/sd/pii/S156757692030494X?token=9233A871CDB32F8395AC4BC24F087F57C760A1B1566282B11CDDD4671BCCD6C10290D0FD37C601A196E806671B47A65D
19. Zhang D, Guo R, Lei L, Liu H, Wang Y, et al. COVID-19 Infection Induces Readily Detectable Morphological and Inflammation-Related Phenotypic Changes in Peripheral Blood Monocytes, the Severity of Which Correlate with Patient Outcome. British Medical Journal. 2020; 1(1):1-17. Available from https://www.medrxiv.org/content/10.1101/2020.03.24.20042655v1.full.pdf
20. Liu W, Li H. COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism. 2020; 1:1-28. Available from https://chemrxiv.org/articles/COVID-19_Disease_ORF8_and_Surface_Glycoprotein_Inhibit_Heme_Metabolism_by_Binding_to_Porphyrin/11938173
21. Young BE, Ong SWX, Kalimuddin S, Low JG, Tan SY, et al. Epidemiologic Features and Clinical Course of Patients Infected with SARS-CoV-2 in Singapore. J Am Med Assoc. 2020; 323(15):1488-1494. doi:10.1001/jama.2020.3204
22. Lippi G, Plebani M. Laboratory Abnormalities in Patients with COVID-2019 Infection. Clin Chem Lab Med. 2020; 1:1-4. Available from https://www.researchgate.net/profile/Giuseppe_Lippi2/publication/339627510_Laboratory_abnormalities_in_patients_with_COVID-2019_infection/links/5e5d20734585152ce8ffa6fb/Laboratory-abnormalities-in-patients-with-COVID-2019-infection.pdf
23. Sarrafzadeh O, Rabbani H, Talebi A, Yousefi-Banaem H. Selection The Best Features for Leukocytes Classification in Blood Smear Microscopic Images. Int Soc Opt Engineering. 2014; 1:1-8. Available from https://www.researchgate.net/profile/Hossein_Rabbani2/publication/263036817_Selection_of_the_best_features_for_leukocytes_classification_in_blood_smear_microscopic_images/links/0a85e53b4372708175000000/Selection-of-the-best-features-for-leukocytes-classification-in-blood-smear-microscopic-images.pdf
24. Liu F, Xu A, Zhang Y, Xuan W, Yan T, et al. Patients of COVID-19 may Benefit from Sustained Lopinavir-combined Regimen and the Increase of Eosinophil may Predict the Outcome of COVID-19 Progression. The Journal of Infectious Diseases. 2020;95(2020)183-191. Available from https://www.ijidonline.com/article/S1201-9712(20)30132-6/pdf
25. Qin C, Zhou L, Zhang S, Yang S, Tao Y, et al. Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China. Infectious Diseases Society of America. 2020; XX(XX):1-7. Available from https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciaa248/33137355/ciaa248.pdf
26. Xu P, Zhou Q, Xu J. Mechanism of Thrombocytopenia in COVID-19 Patients. Annals of Hematology. 2020; XX:1-4. Available from https://doi.org/10.1007/s00277-020-04019-0
27. Mitra A, Dwyre DM, Schivo M, Thompson GR, Cohen SH, et al. Leukoerythroblastic Reaction in a Patient with COVID-19 Infection. Am J Hematol. 2020;1-2. doi: 10.1002/ajh.25793
28. Yang X, Yu Y, Xu J, Shu H, Xia J, et al. Clinical Course and Outcomes of Critically Ill Patients with SARS-CoV-2 Pneumonia in Wuhan, China: a Single-Centered, Retrospective, Observational Study. The Lancet. Elsevier. 2020; 1(1):1-7. Available from https://www.thelancet.com/action/showPdf?pii=S2213-2600%2820%2930079-5
29. Mardani R, Vasmehjani AA, Zali F, Gholami A, Nasab SDM, Kaghazian H, et al. Laboratory Parameters in Detection of COVID-19 Patients with Positive RT-PCR; a Diagnostic Accuracy Study. Arch Acad Emerg Med. 2020; 8(1):e43-48. Available from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130449/pdf/aaem-8-e43.pdf